亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院
Products
News
Resources
Contact
Language
簡體中文
繁體中文
English
日本語
???
Ti?ng Vi?t
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
2025-08-25 12:01
Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform
2025-08-22 18:14
MALAYSIA SHOWCASES HEALTHCARE EXCELLENCE IN CAMBODIA, DRIVING MOMENTUM TOWARDS MYMT 2026
2025-08-22 11:00
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore
2025-08-22 09:55
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results
2025-08-21 18:02
Debut of new form of health supplement product! WCC biomedical collaborate with Synmosa toward the niche market!
2025-08-21 09:23
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
2025-08-21 08:23
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
2025-08-20 08:00
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC
2025-08-19 20:09
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma
2025-08-19 13:26
Beyfortus? (nirsevimab) approved in Singapore to protect all infants against RSV disease
2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries
2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
2025-08-18 21:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS
2025-08-18 18:29
New support group to provide social and community support for neurofibromatosis patients
2025-08-18 09:00
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
2025-08-15 09:35
TraceLink Accelerates Supply Chain Transformation with New OPUS Platform Capabilities for an AI-Powered Future
2025-08-14 22:00
Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma
2025-08-14 17:38
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY? by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis
2025-08-14 12:02
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
2025-08-14 08:00
1
2
3
4
5
271